Mesa Laboratories (NASDAQ: MLAB) — Company Overview, News & Financial Data
Mesa Laboratories develops quality control instrumentation for healthcare and pharmaceuticals, focusing on public health and innovation.
Mesa Laboratories
Mesa Laboratories (NASDAQ:MLAB) is a diversified technology company that specializes in the development, manufacturing, and marketing of instrumentation and solutions for quality control, testing, and measurement. Its key products serve a wide range of industries including healthcare, pharmaceuticals, food and beverage, medical devices, and more. The company is primarily focused on ensuring product quality and promoting public health through its innovative solutions. Mesa Laboratories operates through four main divisions: Sterilization and Disinfection Control, Biopharmaceutical Development, Instruments, and Continuous Monitoring. Forward-looking and dedicated to technological advancement, Mesa Laboratories aims to expand its product lines and enhance its global market presence through strategic acquisitions, partnerships, and research and development initiatives.
Snapshot
Operations
Products and/or services of Mesa Laboratories
- Continuous Monitoring Systems for ensuring the safety and integrity of temperature-sensitive products.
- Biological Indicators for sterilization assurance in healthcare and industrial settings.
- Cold Chain Packaging Solutions for the secure transportation of pharmaceuticals and biologics.
- Calibration Services for precision validation and compliance in various industries.
- Torque Testing Equipment for ensuring the quality and safety of packaging seals.
- Data Loggers for accurate recording and monitoring of environmental parameters.
Mesa Laboratories executive team
- John V. SakysVP & CFO
- Brian David ArchboldSenior Vice President of Operations & Continuous Improvement
- Siddhartha Chandrakant KadiaCEO, President & Director
- Lyndsey CrennenChief Accounting Officer
Dividend history
Dividends per share paid by Mesa Laboratories, by financial year.
| Financial year | Interim | Final | Special | Total |
|---|---|---|---|---|
| FY2027(to date) | — | — | — | $0.4800 |
| FY2026 | — | — | — | $0.6400 |
| FY2025 | — | — | — | $0.6400 |
| FY2024 | — | — | — | $0.6400 |
| FY2023 | — | — | — | $0.6400 |
Key financials
Reported results for Mesa Laboratories, in USD.
- Market cap
- 682.5M
- Revenue (TTM)
- 249.7M
- P/E ratio
- 143.5
- EPS (diluted, TTM)
- 0.8
- Dividend yield
- 0.5%
- Profit margin
- 1.9%
| Fiscal year end | Revenue | Operating income | Net income |
|---|---|---|---|
| 249.1M | 18.5M | 6.7M | |
| 241M | 16.3M | -2M | |
| 216.2M | -272.1M | -254.2M | |
| 219.1M | 3.3M | 930K |